肥胖合并高尿酸血症的治疗:循证医学证据与争议

2016-03-26 佚名 国际糖尿病

随着经济发展、人口老龄化及老年性疾病增多,高尿酸血症和痛风发病率增高已成为全球问题。2016年3月19日,在第七届肥胖与糖尿病论坛上,中山大学孙逸仙纪念医院李焱教授就高尿酸血症和痛风的循证研究进展、减重治疗、降尿酸药物治疗等发表了精彩见解。 高尿酸血症(即男性血尿酸>420μmol/L,女性>360μmol/L)的危害和争议 高尿酸血症与心血管疾病、肥胖、胰岛素抵抗等密切相关,以前被视为代谢综

随着经济发展、人口老龄化及老年性疾病增多,高尿酸血症和痛风发病率增高已成为全球问题。2016年3月19日,在第七届肥胖与糖尿病论坛上,中山大学孙逸仙纪念医院李焱教授就高尿酸血症和痛风的循证研究进展、减重治疗、降尿酸药物治疗等发表了精彩见解。

高尿酸血症(即男性血尿酸>420μmol/L,女性>360μmol/L)的危害和争议

高尿酸血症与心血管疾病、肥胖、胰岛素抵抗等密切相关,以前被视为代谢综合征的一个组分,然而,近几年,高尿酸血症是否是代谢综合征的组成部分存在争议。现在尚不确定高尿酸血症与其他心血管疾病的关系究竟属于伴随现象还是因果关系。高尿酸血症究竟是否需要治疗以及高尿酸血症高到多少水平需要治疗也尚存争议。

目前,高尿酸血症所能确定的最大危害是痛风性关节炎的急性发作,因为与高尿酸血症不同,痛风发作是“看得见”、“摸得着”的。至于干预高尿酸血症是否可以减少或防止肾脏损伤及心血管疾病等,尚缺乏前瞻性研究的支持。一些循证医学证据发现,在已经伴有肾损害的人群中降尿酸治疗可使肾功能得到部分恢复,但这方面证据还不是非常充分。有专家认为,鉴于高尿酸血症有潜在的肾损伤风险,故应积极治疗将尿酸降至正常范围以下,这可能会对预防未来肾损害的发生有所帮助。也有专家认为,目前并无证据显示降低尿酸可减少肾脏疾病。因此,目前,这方面的意见尚不统一。未来,希望能有循证医学证据阐明降低尿酸到底能否减少肾损害及其他危害。

减重这一“亘古不变”的话题,合并痛风的患者怎么做?

首先,虽然运动是有益的,运动确实有助于消耗能量、维持体重,增加肌肉含量、减少脂肪含量,但运动仅是减重的一个方面,并非最主要方面(走一万步所消耗的能量可能仅相当于一块面包所提供的能量而已),除非是非常激烈的消耗量大的运动,日常的散步、跑步等运动的减重意义并不大。减重最主要的方面还是节制饮食、减少能量摄入,因为能量摄入超过机体需求才是导致肥胖的最根本原因。

肥胖本身不仅可诱发痛风性关节炎,还可损伤其他关节。因此,就运动方式而言,合并肥胖的痛风患者可选择散步(快步走或慢步走时需要走到一定的程度,但不能负重走路)、慢跑,也可适当进行上肢或全身抗阻力运动。对于年龄偏大、体型较胖或已经有痛风性关节炎发作者,不能进行过于激烈运动,走路及慢步可能是比较合适的运动选择。我们不主张这些患者选择上下楼梯、爬山等对关节损害很大的运动方式。

对现在比较流行的瑜伽及健美操等,这些运动方式主要是增加身体柔韧性,虽然也会消耗一部分能量,但减重效果还是需要饮食配合。因为这种柔韧性训练对能量的消耗并不是非常激烈,做一次瑜伽并不能消耗太多能量。

无症状高尿酸血症的治疗标准是什么?

我个人认为,应坚持个体化治疗。若患者较年轻、血尿酸水平较高且合并显著痛风发作诱发因素或可造成肾脏损害的其他危险因素(如肥胖及心血管高危因素),可能需要采取更积极的治疗策略。若患者血尿酸仅轻度增高且无其他危险因素(如肾脏结石),则可能并不需要进行积极降尿酸治疗。

从预防痛风发作的角度而言,无症状高尿酸血症患者需要将血尿酸降至<360μmol/L,若患者已经合并痛风结石需要溶解,则需要将血尿酸降至<300μmol/L。就肾脏保护及心脏保护而言,目前尚缺乏需要将尿酸降至多少的相关证据,从理论上来说,可能降得更低会更好一些。

降尿酸药物的安全性

2012年美国风湿病学会(ACR)建议在应用降尿酸药物前有条件时进行基因检测,以避免别嘌呤醇对白细胞抗原HLA-B*5801基因阳性者的严重不良反应。到目前为止,中国只有台湾的指南作了特殊规定,指出要对这些人群进行特殊监测,这主要是因为亚洲人群中上述基因阳性的患者较多,而一旦这些患者出现严重不良反应可致命。现在基因检测方法已经非常普及,并不是非常昂贵。因此,若有条件,进行上述基因检测会更好。鉴于一旦出现严重过敏反应有可能致命,故若无条件则一定要与患者进行充分沟通。若沟通不清楚,则容易导致医疗纠纷。当然,有些抑制尿酸生成的新药(如非布司他)以及传统的促尿酸排泄药物如苯溴马隆并没有这方面的不良反应。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=76607, encodeId=dfdbe6607aa, content=临床上真不想处理痛风的病人,效果差!, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a0f1522553, createdName=willyml, createdTime=Sat Apr 09 16:55:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74483, encodeId=d85ce4483d2, content=Bucuode, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74484, encodeId=58f8e4484eb, content=不错的轮完, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74485, encodeId=19e2e44852d, content=不措施啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379454, encodeId=5e8613e945471, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449679, encodeId=697014496e90e, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476741, encodeId=6bc514e67418b, content=<a href='/topic/show?id=f915102342ea' target=_blank style='color:#2F92EE;'>#高尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102342, encryptionId=f915102342ea, topicName=高尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f17331078, createdName=ms622625817193301, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73952, encodeId=0f12e395251, content=相关性不清楚,治疗不确切,循证医学证据不多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=225a1697989, createdName=1de7460am01(暂无匿称), createdTime=Sun Mar 27 07:07:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73935, encodeId=278ce39357f, content=~(??﹏?⊙☆)ノ凌乱, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Sun Mar 27 01:20:00 CST 2016, time=2016-03-27, status=1, ipAttribution=)]
    2016-04-09 willyml

    临床上真不想处理痛风的病人,效果差!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=76607, encodeId=dfdbe6607aa, content=临床上真不想处理痛风的病人,效果差!, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a0f1522553, createdName=willyml, createdTime=Sat Apr 09 16:55:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74483, encodeId=d85ce4483d2, content=Bucuode, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74484, encodeId=58f8e4484eb, content=不错的轮完, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74485, encodeId=19e2e44852d, content=不措施啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379454, encodeId=5e8613e945471, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449679, encodeId=697014496e90e, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476741, encodeId=6bc514e67418b, content=<a href='/topic/show?id=f915102342ea' target=_blank style='color:#2F92EE;'>#高尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102342, encryptionId=f915102342ea, topicName=高尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f17331078, createdName=ms622625817193301, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73952, encodeId=0f12e395251, content=相关性不清楚,治疗不确切,循证医学证据不多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=225a1697989, createdName=1de7460am01(暂无匿称), createdTime=Sun Mar 27 07:07:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73935, encodeId=278ce39357f, content=~(??﹏?⊙☆)ノ凌乱, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Sun Mar 27 01:20:00 CST 2016, time=2016-03-27, status=1, ipAttribution=)]
    2016-03-30 三毛坨

    Bucuode

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=76607, encodeId=dfdbe6607aa, content=临床上真不想处理痛风的病人,效果差!, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a0f1522553, createdName=willyml, createdTime=Sat Apr 09 16:55:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74483, encodeId=d85ce4483d2, content=Bucuode, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74484, encodeId=58f8e4484eb, content=不错的轮完, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74485, encodeId=19e2e44852d, content=不措施啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379454, encodeId=5e8613e945471, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449679, encodeId=697014496e90e, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476741, encodeId=6bc514e67418b, content=<a href='/topic/show?id=f915102342ea' target=_blank style='color:#2F92EE;'>#高尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102342, encryptionId=f915102342ea, topicName=高尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f17331078, createdName=ms622625817193301, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73952, encodeId=0f12e395251, content=相关性不清楚,治疗不确切,循证医学证据不多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=225a1697989, createdName=1de7460am01(暂无匿称), createdTime=Sun Mar 27 07:07:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73935, encodeId=278ce39357f, content=~(??﹏?⊙☆)ノ凌乱, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Sun Mar 27 01:20:00 CST 2016, time=2016-03-27, status=1, ipAttribution=)]
    2016-03-30 三毛坨

    不错的轮完

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=76607, encodeId=dfdbe6607aa, content=临床上真不想处理痛风的病人,效果差!, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a0f1522553, createdName=willyml, createdTime=Sat Apr 09 16:55:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74483, encodeId=d85ce4483d2, content=Bucuode, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74484, encodeId=58f8e4484eb, content=不错的轮完, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74485, encodeId=19e2e44852d, content=不措施啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379454, encodeId=5e8613e945471, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449679, encodeId=697014496e90e, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476741, encodeId=6bc514e67418b, content=<a href='/topic/show?id=f915102342ea' target=_blank style='color:#2F92EE;'>#高尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102342, encryptionId=f915102342ea, topicName=高尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f17331078, createdName=ms622625817193301, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73952, encodeId=0f12e395251, content=相关性不清楚,治疗不确切,循证医学证据不多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=225a1697989, createdName=1de7460am01(暂无匿称), createdTime=Sun Mar 27 07:07:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73935, encodeId=278ce39357f, content=~(??﹏?⊙☆)ノ凌乱, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Sun Mar 27 01:20:00 CST 2016, time=2016-03-27, status=1, ipAttribution=)]
    2016-03-30 三毛坨

    不措施啊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=76607, encodeId=dfdbe6607aa, content=临床上真不想处理痛风的病人,效果差!, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a0f1522553, createdName=willyml, createdTime=Sat Apr 09 16:55:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74483, encodeId=d85ce4483d2, content=Bucuode, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74484, encodeId=58f8e4484eb, content=不错的轮完, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74485, encodeId=19e2e44852d, content=不措施啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379454, encodeId=5e8613e945471, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449679, encodeId=697014496e90e, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476741, encodeId=6bc514e67418b, content=<a href='/topic/show?id=f915102342ea' target=_blank style='color:#2F92EE;'>#高尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102342, encryptionId=f915102342ea, topicName=高尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f17331078, createdName=ms622625817193301, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73952, encodeId=0f12e395251, content=相关性不清楚,治疗不确切,循证医学证据不多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=225a1697989, createdName=1de7460am01(暂无匿称), createdTime=Sun Mar 27 07:07:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73935, encodeId=278ce39357f, content=~(??﹏?⊙☆)ノ凌乱, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Sun Mar 27 01:20:00 CST 2016, time=2016-03-27, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=76607, encodeId=dfdbe6607aa, content=临床上真不想处理痛风的病人,效果差!, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a0f1522553, createdName=willyml, createdTime=Sat Apr 09 16:55:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74483, encodeId=d85ce4483d2, content=Bucuode, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74484, encodeId=58f8e4484eb, content=不错的轮完, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74485, encodeId=19e2e44852d, content=不措施啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379454, encodeId=5e8613e945471, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449679, encodeId=697014496e90e, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476741, encodeId=6bc514e67418b, content=<a href='/topic/show?id=f915102342ea' target=_blank style='color:#2F92EE;'>#高尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102342, encryptionId=f915102342ea, topicName=高尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f17331078, createdName=ms622625817193301, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73952, encodeId=0f12e395251, content=相关性不清楚,治疗不确切,循证医学证据不多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=225a1697989, createdName=1de7460am01(暂无匿称), createdTime=Sun Mar 27 07:07:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73935, encodeId=278ce39357f, content=~(??﹏?⊙☆)ノ凌乱, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Sun Mar 27 01:20:00 CST 2016, time=2016-03-27, status=1, ipAttribution=)]
    2016-03-28 xjy04
  7. [GetPortalCommentsPageByObjectIdResponse(id=76607, encodeId=dfdbe6607aa, content=临床上真不想处理痛风的病人,效果差!, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a0f1522553, createdName=willyml, createdTime=Sat Apr 09 16:55:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74483, encodeId=d85ce4483d2, content=Bucuode, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74484, encodeId=58f8e4484eb, content=不错的轮完, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74485, encodeId=19e2e44852d, content=不措施啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379454, encodeId=5e8613e945471, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449679, encodeId=697014496e90e, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476741, encodeId=6bc514e67418b, content=<a href='/topic/show?id=f915102342ea' target=_blank style='color:#2F92EE;'>#高尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102342, encryptionId=f915102342ea, topicName=高尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f17331078, createdName=ms622625817193301, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73952, encodeId=0f12e395251, content=相关性不清楚,治疗不确切,循证医学证据不多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=225a1697989, createdName=1de7460am01(暂无匿称), createdTime=Sun Mar 27 07:07:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73935, encodeId=278ce39357f, content=~(??﹏?⊙☆)ノ凌乱, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Sun Mar 27 01:20:00 CST 2016, time=2016-03-27, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=76607, encodeId=dfdbe6607aa, content=临床上真不想处理痛风的病人,效果差!, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a0f1522553, createdName=willyml, createdTime=Sat Apr 09 16:55:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74483, encodeId=d85ce4483d2, content=Bucuode, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74484, encodeId=58f8e4484eb, content=不错的轮完, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74485, encodeId=19e2e44852d, content=不措施啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379454, encodeId=5e8613e945471, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449679, encodeId=697014496e90e, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476741, encodeId=6bc514e67418b, content=<a href='/topic/show?id=f915102342ea' target=_blank style='color:#2F92EE;'>#高尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102342, encryptionId=f915102342ea, topicName=高尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f17331078, createdName=ms622625817193301, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73952, encodeId=0f12e395251, content=相关性不清楚,治疗不确切,循证医学证据不多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=225a1697989, createdName=1de7460am01(暂无匿称), createdTime=Sun Mar 27 07:07:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73935, encodeId=278ce39357f, content=~(??﹏?⊙☆)ノ凌乱, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Sun Mar 27 01:20:00 CST 2016, time=2016-03-27, status=1, ipAttribution=)]
    2016-03-27 1de7460am01(暂无匿称)

    相关性不清楚,治疗不确切,循证医学证据不多。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=76607, encodeId=dfdbe6607aa, content=临床上真不想处理痛风的病人,效果差!, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a0f1522553, createdName=willyml, createdTime=Sat Apr 09 16:55:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74483, encodeId=d85ce4483d2, content=Bucuode, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74484, encodeId=58f8e4484eb, content=不错的轮完, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=74485, encodeId=19e2e44852d, content=不措施啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f41674911, createdName=三毛坨, createdTime=Wed Mar 30 01:39:00 CST 2016, time=2016-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379454, encodeId=5e8613e945471, content=<a href='/topic/show?id=4f12504e147' target=_blank style='color:#2F92EE;'>#循证医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50471, encryptionId=4f12504e147, topicName=循证医学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49cf452, createdName=xsm918, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449679, encodeId=697014496e90e, content=<a href='/topic/show?id=0bd850468be' target=_blank style='color:#2F92EE;'>#循证#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50468, encryptionId=0bd850468be, topicName=循证)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca95510093, createdName=xjy04, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476741, encodeId=6bc514e67418b, content=<a href='/topic/show?id=f915102342ea' target=_blank style='color:#2F92EE;'>#高尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102342, encryptionId=f915102342ea, topicName=高尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f17331078, createdName=ms622625817193301, createdTime=Mon Mar 28 06:48:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73952, encodeId=0f12e395251, content=相关性不清楚,治疗不确切,循证医学证据不多。, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=225a1697989, createdName=1de7460am01(暂无匿称), createdTime=Sun Mar 27 07:07:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73935, encodeId=278ce39357f, content=~(??﹏?⊙☆)ノ凌乱, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Sun Mar 27 01:20:00 CST 2016, time=2016-03-27, status=1, ipAttribution=)]
    2016-03-27 cjingjuan

    ~(??﹏?⊙☆)ノ凌乱

    0

相关资讯

JAMA:生命早期的抗生素暴露不会增加儿童期的肥胖风险

在动物模型中的结果显示生命早期的抗生素暴露可增加肥胖的风险,这是通过肠道微生物介导的。婴儿抗生素暴露较为常见,且经常使用不恰当。婴儿使用抗生素和儿童体重增加之间的关系的研究报告结果不一致。原始出处:Jeffrey S. Gerber,Matthew Bryan,Rachael K. Ross,et al.Antibiotic Exposure During the First 6 Months o

Gastroenterology:婴儿期使用抗生素,增加儿童期的肥胖风险

婴儿期使用抗生素会为婴儿带来许多不利风险,一项新的研究表明,婴儿期使用抗生素增加儿童肥胖风险。研究发表在journal of the American Gastroenterological Association。研究发现,小儿2岁前使用3种或3种以上抗生素处方会增加他们肥胖的风险。 科罗拉多大学医学副教授Frank Irving Scott博士指出,近几十年来通过研究证实,对牲畜使用抗生素会增

BJOG:孕期肥胖或增加孩子行为问题的风险

近期发表在BJOG: An International Journal of Obstetrics and Gynaecology的研究称,母亲肥胖会小幅度增加儿童行为问题的风险。匹兹堡大学的Sarah J. Pugh和同事对511对母亲-婴儿对从妊娠开始,随访到10岁,探究后代注意缺损多动障碍(ADHD)症状和情绪/行为障碍与母亲妊娠期体重增加(GWG)的关系。使用康纳斯的连续性能测试评估后代A

Clin Gastroenterol Hepatol:胖子得胰腺癌,死亡率会更高吗?

发表在Clin Gastroenterol Hepatol的荟萃分析称,西方人群中胰腺癌患者发病肥胖与高死亡率有关。研究者将纳入的13项研究中胰腺癌患者的BMI进行合并分类:超重组、肥胖组和正常BMI组(对照组),然后进行荟萃分析。需要指出的是,13项研究中有8项研究的参与者在纳入研究时,没有患上胰腺癌,不过后期的随访过程中,保留了与胰腺癌发病和死亡相关的数据。荟萃分析结果显示,死亡风险比较:超重

ACC 2016:心脏病发作呈现年轻化!

在芝加哥举行的第65届美国心脏病学会科学会议称,严重心脏病发作患者呈现更年轻、更胖的趋势,相关危险因素还有高血压、糖尿病、慢性阻塞性肺疾病等。心脏病发作的危险因素有年龄和家族史,这是不可控制的因素。此外心脏健康还和饮食、运动、吸烟等有关,而这些是个体可以选择可以控制的。近几年,心血管疾病发病率积剧上升,当前已经到了迫切需要预防策略的时刻。ST段抬高型心肌梗死(STEMI)是最严重的致命性心脏病发作

65th ACC:关注女性心脏健康刻不容缓

女性就诊时,医生往往建议她们减肥而未提醒她们关注心脏健康。研究人员将会在即将召开的第65届美国心脏病学会会议上提出这项观点。尽管女性出现心脏疾病的时间较男性晚7-10年,它仍是导致民众死亡的主要原因。在过去的20年里,女性在35-54岁时出现心肌梗死的人数增加,同年龄段男性人数减少。且在1997-2002年间,35-44岁的女性发生冠心病的发病率每年增加1.3%。 C. Noel Bairey M